AMRN – Amarin Corp ADR

AMRN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.23

Margin Of Safety %

-24

Put/Call OI Ratio

0.17

EPS Next Q Diff

0.19

EPS Last/This Y

1.79

EPS This/Next Y

0.99

Price

14.47

Target Price

12.5

Analyst Recom

Performance Q

-1.22

Upside

-489.4%

Beta

0.83

Ticker: AMRN

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-20	AMRN	14.51	0.15	0.07	2061
2026-04-23	AMRN	14.77	0.13	0.07	2404
2026-04-24	AMRN	14.35	0.13	0.03	2428
2026-04-27	AMRN	13.93	0.13	0.44	2473
2026-04-28	AMRN	13.9001	0.14	0.13	2577
2026-04-29	AMRN	14.24	0.14	0.20	2801
2026-04-30	AMRN	13.88	0.15	0.21	2847
2026-05-01	AMRN	13.99	0.15	0.41	2908
2026-05-04	AMRN	14.2	0.16	0.02	2963
2026-05-05	AMRN	14.52	0.16	0.03	2976
2026-05-06	AMRN	14.95	0.16	0.35	3014
2026-05-07	AMRN	14.78	0.16	0.40	3062
2026-05-08	AMRN	15.05	0.16	1.11	3080
2026-05-11	AMRN	14.94	0.16	0.06	3116
2026-05-12	AMRN	14.95	0.17	0.00	3115
2026-05-13	AMRN	15.05	0.17	0.13	3116
2026-05-14	AMRN	14.77	0.17	0.04	3153
2026-05-15	AMRN	14.5	0.17	2.40	3215
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-16	AMRN	14.65	142.5	-	0.78
2026-04-17	AMRN	14.97	142.5	-	0.78
2026-04-20	AMRN	14.57	142.5	-	0.78
2026-04-21	AMRN	14.59	142.5	-	0.78
2026-04-22	AMRN	14.49	142.5	-	0.78
2026-04-23	AMRN	14.73	142.5	-	0.78
2026-04-24	AMRN	14.34	142.5	-	0.78
2026-04-27	AMRN	13.93	142.5	-	0.78
2026-04-28	AMRN	13.95	142.5	-	0.78
2026-04-30	AMRN	13.86	142.5	-	0.78
2026-05-01	AMRN	13.97	142.5	-	0.78
2026-05-04	AMRN	14.22	-80.5	-	0.78
2026-05-05	AMRN	14.45	-80.5	-	0.78
2026-05-06	AMRN	14.90	-80.5	-	0.78
2026-05-07	AMRN	14.82	-80.5	-	0.78
2026-05-08	AMRN	15.00	-80.5	-	-0.01
2026-05-11	AMRN	14.94	-111.5	-	-0.01
2026-05-12	AMRN	14.95	-111.5	-	-0.01
2026-05-13	AMRN	15.11	-111.5	-	-0.01
2026-05-14	AMRN	14.72	-111.5	-	-0.01
2026-05-15	AMRN	14.47	-111.5	-	-0.01
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-16	AMRN	0.00	-0.02	2.20
2026-04-17	AMRN	0.00	-0.02	2.20
2026-04-20	AMRN	0.00	-0.02	2.20
2026-04-21	AMRN	0.00	-0.02	2.20
2026-04-22	AMRN	0.00	-0.02	2.20
2026-04-23	AMRN	0.00	-0.02	2.20
2026-04-24	AMRN	0.00	-0.02	2.20
2026-04-27	AMRN	0.00	-0.01	2.06
2026-04-28	AMRN	0.00	-0.01	2.06
2026-04-29	AMRN	0.00	-0.01	2.06
2026-04-30	AMRN	0.00	-0.01	2.06
2026-05-01	AMRN	0.00	-0.01	2.06
2026-05-04	AMRN	0.00	-0.01	0
2026-05-05	AMRN	0.00	-0.01	2.04
2026-05-06	AMRN	0.00	-0.01	2.04
2026-05-07	AMRN	0.00	-0.01	2.04
2026-05-08	AMRN	0.00	-0.01	2.04
2026-05-11	AMRN	0.00	0.02	2.04
2026-05-12	AMRN	0.00	0.02	3.23
2026-05-13	AMRN	0.00	0.02	3.23
2026-05-14	AMRN	0.00	0.02	3.23
2026-05-15	AMRN	0.00	0.02	3.23
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.2

Avg. EPS Est. Current Quarter

-0.1

Avg. EPS Est. Next Quarter

-0.01

Insider Transactions

Institutional Transactions

0.02

Beta

0.83

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

10.98

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

87.9

Max Drawdown 5-Year %

-93.1

Target Price

12.5

P/E

Forward P/E

264.73

PEG

P/S

1.41

P/B

0.68

P/Free Cash Flow

EPS

-1.62

Average EPS Est. Cur. Y

-0.01

EPS Next Y. (Est.)

0.98

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-15.52

Relative Volume

0.75

Return on Equity vs Sector %

-34.4

Return on Equity vs Industry %

-44.5

EPS 1 7Days Diff

-0.8

EPS 1 30Days Diff

-0.79

EBIT Estimation

◆ AMRN Healthcare

$14.56

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

10/20

Pullback

9/25

Volume

9/15

Valuation

9/20

TP/AR

0/10

Options

6/10

RSI

48.3

Range 1M

59.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

23/30

Estimates

2/20

Inst/Vol

3/15

Options

7/10

EPS Yr

61.1%

EPS NY

257.1%

52W%

39.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +57.6% upside

Quality

5/30

Valuation

15/30

Growth

19/25

Stability

7/10

LT Trend

4/5

Upside

+57.6%

Quality

MoS

-24%

Amarin Corporation plc

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 80

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

AMRN

Latest News

—

Caricamento notizie per AMRN…

stock quote shares AMRN – Amarin Corp ADR Stock Price stock today

news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRN – Amarin Corp ADR yahoo finance google finance

stock history AMRN – Amarin Corp ADR invest stock market

stock prices AMRN premarket after hours

ticker AMRN fair value insiders trading

GRFS – Grifols, S.A.

GRFS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.09

Margin Of Safety %

Put/Call OI Ratio

0.37

EPS Next Q Diff

EPS Last/This Y

0.37

EPS This/Next Y

0.38

Price

7.66

Target Price

14.43

Analyst Recom

Performance Q

-11.03

Upside

N/A

Beta

0.67

Ticker: GRFS

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-20	GRFS	8.47	0.31	0.64	2552
2026-04-23	GRFS	7.99	0.33	4.05	2602
2026-04-24	GRFS	8.09	0.37	0.07	2712
2026-04-27	GRFS	8.12	0.37	0.67	2734
2026-04-28	GRFS	8.07	0.37	0.00	2742
2026-04-29	GRFS	7.91	0.35	10.00	2836
2026-04-30	GRFS	8.22	0.35	10.00	2836
2026-05-01	GRFS	8.23	0.35	10.00	2836
2026-05-04	GRFS	8.23	0.37	1.58	2866
2026-05-05	GRFS	8.27	0.39	999.99	2916
2026-05-06	GRFS	8.41	0.39	77.00	2917
2026-05-07	GRFS	8.06	0.42	3.17	2978
2026-05-08	GRFS	8.09	0.45	0.10	3029
2026-05-11	GRFS	7.8	0.42	0.17	2982
2026-05-12	GRFS	7.55	0.42	0.13	2982
2026-05-13	GRFS	7.7	0.38	0.17	3416
2026-05-14	GRFS	7.8	0.38	0.06	3410
2026-05-15	GRFS	7.66	0.37	999.99	3458
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-16	GRFS	8.60	-	-	1.17
2026-04-17	GRFS	8.73	-	-	1.17
2026-04-20	GRFS	8.48	-	-	1.17
2026-04-21	GRFS	8.38	-	-	1.17
2026-04-22	GRFS	8.38	-	-	1.17
2026-04-23	GRFS	7.99	-	-	1.17
2026-04-24	GRFS	8.09	-	-	1.17
2026-04-27	GRFS	8.13	-	-	1.17
2026-04-28	GRFS	8.08	-	-	1.17
2026-04-30	GRFS	8.23	-	-	1.17
2026-05-01	GRFS	8.23	-	-	1.17
2026-05-04	GRFS	8.23	-	-	1.17
2026-05-05	GRFS	8.28	-	-	1.17
2026-05-06	GRFS	8.40	-	-	1.17
2026-05-07	GRFS	8.06	-	-	1.17
2026-05-08	GRFS	8.08	-	-	1.17
2026-05-11	GRFS	7.80	-	-	1.17
2026-05-12	GRFS	7.55	23.9	-	1.17
2026-05-13	GRFS	7.69	23.9	-	1.17
2026-05-14	GRFS	7.79	23.9	-	1.17
2026-05-15	GRFS	7.66	23.9	-	1.06
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

12 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-16	GRFS	0	-1.20	2.04
2026-04-17	GRFS	0	-1.20	2.04
2026-04-20	GRFS	0	-1.42	2.04
2026-04-21	GRFS	0	-1.42	2.04
2026-04-22	GRFS	0	-1.42	2.04
2026-04-23	GRFS	0	-1.42	2.04
2026-04-24	GRFS	0.00	-1.42	2.04
2026-04-27	GRFS	0.00	-1.31	2.09
2026-04-28	GRFS	0.00	-1.31	2.09
2026-04-29	GRFS	0.00	-1.31	2.09
2026-04-30	GRFS	0.00	-1.31	2.09
2026-05-01	GRFS	0.00	-1.31	2.09
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

12 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.28

Avg. EPS Est. Next Quarter

0.29

Insider Transactions

Institutional Transactions

-1.31

Beta

0.67

Average Sales Estimate Current Quarter

1951

Average Sales Estimate Next Quarter

1971

Fair Value

11.15

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

59.8

Max Drawdown 5-Year %

-70.7

Target Price

14.43

P/E

12.21

Forward P/E

6.24

PEG

0.28

P/S

0.25

P/B

0.9

P/Free Cash Flow

2.4

EPS

0.67

Average EPS Est. Cur. Y

1.06

EPS Next Y. (Est.)

1.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.39

Relative Volume

0.19

Return on Equity vs Sector %

-19.3

Return on Equity vs Industry %

-29.4

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.11

EBIT Estimation

No data found for GRFS

Grifols, S.A.

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 25000

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

GRFS

Latest News

—

Caricamento notizie per GRFS…

stock quote shares GRFS – Grifols, S.A. Stock Price stock today

news today GRFS – Grifols, S.A. stock forecast ,stock prediction 2023 2024 2025

marketwatch GRFS – Grifols, S.A. yahoo finance google finance

stock history GRFS – Grifols, S.A. invest stock market

stock prices GRFS premarket after hours

ticker GRFS fair value insiders trading

SNY – Sanofi

SNY — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.33

Margin Of Safety %

Put/Call OI Ratio

1.04

EPS Next Q Diff

0.55

EPS Last/This Y

1.07

EPS This/Next Y

0.37

Price

42.7

Target Price

53.92

Analyst Recom

2.29

Performance Q

-7.22

Upside

-27.2%

Beta

0.31

Ticker: SNY

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-20	SNY	47.97	1.11	0.32	49057
2026-04-23	SNY	47.56	1.11	0.11	53063
2026-04-24	SNY	46.81	1.19	0.33	51942
2026-04-27	SNY	45.91	1.20	0.98	52161
2026-04-28	SNY	45.97	1.20	0.54	52805
2026-04-29	SNY	46.04	1.20	1.10	52895
2026-04-30	SNY	46.57	1.21	0.82	54701
2026-05-01	SNY	46.1	1.21	0.06	55824
2026-05-04	SNY	43.31	1.31	1.03	55308
2026-05-05	SNY	43.39	1.24	0.14	55494
2026-05-06	SNY	43.74	1.18	0.26	56449
2026-05-07	SNY	43.19	1.15	0.11	56833
2026-05-08	SNY	43.31	1.10	0.18	57242
2026-05-11	SNY	42.5	1.08	0.51	58160
2026-05-12	SNY	42.85	1.07	0.84	58391
2026-05-13	SNY	42.44	1.06	0.86	59576
2026-05-14	SNY	42.85	1.06	0.47	60839
2026-05-15	SNY	42.69	1.04	0.31	61626
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-16	SNY	47.70	0.5	4314.9	4.97
2026-04-17	SNY	48.08	0.5	4478.8	4.97
2026-04-20	SNY	47.97	0.5	4298.1	4.97
2026-04-21	SNY	47.11	0.5	4200.5	4.97
2026-04-22	SNY	46.90	0.5	4285.6	4.97
2026-04-23	SNY	47.53	0.5	4462.1	4.83
2026-04-24	SNY	46.78	0.5	3970.1	4.83
2026-04-27	SNY	45.89	24.3	4476.6	4.83
2026-04-28	SNY	45.96	24.3	4648.6	4.96
2026-04-30	SNY	46.58	24.3	4892.0	4.96
2026-05-01	SNY	46.10	24.3	4576.7	4.80
2026-05-04	SNY	43.31	24.3	4294.8	4.80
2026-05-05	SNY	43.37	24.3	4778.2	4.81
2026-05-06	SNY	43.74	24.3	4865.3	4.81
2026-05-07	SNY	43.19	24.3	4348.9	4.81
2026-05-08	SNY	43.29	24.3	4498.9	4.81
2026-05-11	SNY	42.49	24.3	4438.2	4.81
2026-05-12	SNY	42.85	24.3	4507.7	4.81
2026-05-13	SNY	42.44	24.3	4412.5	4.81
2026-05-14	SNY	42.86	24.3	4606.5	4.81
2026-05-15	SNY	42.70	24.3	4496.0	4.81
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-16	SNY	0.00	-4.88	0.31
2026-04-17	SNY	0.00	-4.88	0.31
2026-04-20	SNY	0.00	-4.92	0.31
2026-04-21	SNY	0.00	-4.92	0.31
2026-04-22	SNY	0.00	-4.92	0.31
2026-04-23	SNY	0.00	-4.92	0.31
2026-04-24	SNY	0	-4.92	0.31
2026-04-27	SNY	0	-5.80	0.32
2026-04-28	SNY	0	-5.80	0.32
2026-04-29	SNY	0	-5.80	0.32
2026-04-30	SNY	0	-5.80	0.32
2026-05-01	SNY	0	-5.80	0.32
2026-05-04	SNY	0	-3.12	0.32
2026-05-05	SNY	0	-3.12	0.32
2026-05-06	SNY	0	-3.12	0.32
2026-05-07	SNY	0	-3.12	0.32
2026-05-08	SNY	0	-3.12	0.32
2026-05-11	SNY	0	-3.67	0.32
2026-05-12	SNY	0	-3.67	0.33
2026-05-13	SNY	0	-3.67	0
2026-05-14	SNY	0	-3.67	0.33
2026-05-15	SNY	0	-3.67	0.33
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

1.1

Avg. EPS Est. Current Quarter

1.13

Avg. EPS Est. Next Quarter

1.65

Insider Transactions

Institutional Transactions

-3.67

Beta

0.31

Average Sales Estimate Current Quarter

10812

Average Sales Estimate Next Quarter

13273

Fair Value

57.33

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-33.5

Target Price

53.92

P/E

17.88

Forward P/E

8.02

PEG

1.1

P/S

2.07

P/B

1.23

P/Free Cash Flow

9.78

EPS

2.39

Average EPS Est. Cur. Y

4.81

EPS Next Y. (Est.)

5.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.81

Relative Volume

0.79

Return on Equity vs Sector %

-21.7

Return on Equity vs Industry %

-31.8

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.2

EBIT Estimation

4496

◆ SNY Healthcare

$42.69

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

21/25

Volume

9/15

Valuation

18/20

TP/AR

1/10

Options

3/10

RSI

Range 1M

7.4%

Sup Dist

0.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

9/30

Estimates

5/20

Inst/Vol

0/15

Options

6/10

EPS Yr

EPS NY

6.5%

52W%

4.2%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +44.6% upside

Quality

14/30

Valuation

20/30

Growth

7/25

Stability

3/10

LT Trend

1/5

Upside

+44.6%

Quality

MoS

34%

Sanofi

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 74846

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

SNY

Latest News

—

Caricamento notizie per SNY…

stock quote shares SNY – Sanofi Stock Price stock today

news today SNY – Sanofi stock forecast ,stock prediction 2023 2024 2025

marketwatch SNY – Sanofi yahoo finance google finance

stock history SNY – Sanofi invest stock market

stock prices SNY premarket after hours

ticker SNY fair value insiders trading

NVO – Novo Nordisk A/S

NVO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.42

Margin Of Safety %

-14

Put/Call OI Ratio

0.69

EPS Next Q Diff

3.69

EPS Last/This Y

19.77

EPS This/Next Y

-1.79

Price

44.72

Target Price

48.9

Analyst Recom

2.5

Performance Q

-9.77

Upside

23.8%

Beta

0.79

Ticker: NVO

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-20	NVO	40.46	0.71	0.63	1363091
2026-04-23	NVO	38.5	0.71	0.47	1443266
2026-04-24	NVO	41.15	0.71	0.27	1458931
2026-04-27	NVO	41.18	0.68	0.29	1435545
2026-04-28	NVO	41.17	0.67	0.21	1475040
2026-04-29	NVO	40.28	0.67	0.54	1488866
2026-04-30	NVO	42.2	0.68	0.30	1521125
2026-05-01	NVO	43.88	0.68	0.44	1539834
2026-05-04	NVO	44.4	0.69	0.29	1515880
2026-05-05	NVO	44.9	0.69	0.50	1537073
2026-05-06	NVO	45.74	0.68	0.39	1584436
2026-05-07	NVO	45.81	0.68	0.42	1592900
2026-05-08	NVO	46.09	0.68	0.28	1603572
2026-05-11	NVO	46.4	0.69	0.38	1501570
2026-05-12	NVO	46.97	0.69	0.34	1510947
2026-05-13	NVO	47.08	0.69	0.52	1519844
2026-05-14	NVO	45.81	0.69	0.28	1531138
2026-05-15	NVO	44.72	0.69	0.62	1535072
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-16	NVO	40.92	4.6	-1169.2	21.44
2026-04-17	NVO	40.50	6.6	-1725.0	21.44
2026-04-20	NVO	40.47	6.6	-1955.0	21.44
2026-04-21	NVO	39.42	6.6	-2083.0	21.87
2026-04-22	NVO	39.15	6.6	-1281.1	21.87
2026-04-23	NVO	38.51	6.6	-1706.9	21.98
2026-04-24	NVO	41.17	6.6	-327.7	21.98
2026-04-27	NVO	41.19	6.6	-1280.7	21.98
2026-04-28	NVO	41.16	6.6	-1799.2	21.98
2026-04-30	NVO	42.20	6.6	-816.1	21.98
2026-05-01	NVO	43.88	6.6	-1257.0	21.98
2026-05-04	NVO	44.40	6.6	-1418.3	21.98
2026-05-05	NVO	44.90	6.6	-1533.3	21.98
2026-05-06	NVO	45.75	6.6	-1402.4	21.98
2026-05-07	NVO	45.78	6.6	-14501.7	21.98
2026-05-08	NVO	46.08	6.6	-14310.4	21.98
2026-05-11	NVO	46.40	-12.9	-13530.0	26.55
2026-05-12	NVO	46.98	-12.9	-13986.1	23.37
2026-05-13	NVO	47.08	-12.9	-13848.8	23.37
2026-05-14	NVO	45.79	-12.9	-14208.4	23.37
2026-05-15	NVO	44.72	-12.9	-14433.0	23.37
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-16	NVO	0.00	0.16	0.59
2026-04-17	NVO	0.00	0.16	0.59
2026-04-20	NVO	0.00	0.06	0.59
2026-04-21	NVO	0.00	0.06	0.59
2026-04-22	NVO	0.00	0.06	0.59
2026-04-23	NVO	0.00	0.06	0.59
2026-04-24	NVO	0	0.06	0.59
2026-04-27	NVO	0	-0.15	0.51
2026-04-28	NVO	0	-0.15	0.51
2026-04-29	NVO	0	-0.15	0.51
2026-04-30	NVO	0	-0.15	0.51
2026-05-01	NVO	0	-0.15	0.51
2026-05-04	NVO	0	-0.36	0.51
2026-05-05	NVO	0	-0.36	0.51
2026-05-06	NVO	0	-0.36	0.51
2026-05-07	NVO	0	-0.36	0.51
2026-05-08	NVO	0	-0.36	0.51
2026-05-11	NVO	0	-0.56	0
2026-05-12	NVO	0	-0.56	0.42
2026-05-13	NVO	0	-0.56	0.42
2026-05-14	NVO	0	-0.56	0.42
2026-05-15	NVO	0	-0.56	0.42
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

1.04

Avg. EPS Est. Current Quarter

5.19

Avg. EPS Est. Next Quarter

4.73

Insider Transactions

Institutional Transactions

-0.56

Beta

0.79

Average Sales Estimate Current Quarter

72241

Average Sales Estimate Next Quarter

71299

Fair Value

38.45

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

69.8

Max Drawdown 5-Year %

-74.7

Target Price

48.9

P/E

10.5

Forward P/E

13.41

PEG

53.64

P/S

2.96

P/B

6.35

P/Free Cash Flow

23.49

EPS

4.26

Average EPS Est. Cur. Y

23.37

EPS Next Y. (Est.)

21.58

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

37.23

Relative Volume

0.8

Return on Equity vs Sector %

33.1

Return on Equity vs Industry %

EPS 1 7Days Diff

1.4

EPS 1 30Days Diff

1.91

EBIT Estimation

-14433

◆ NVO Healthcare

$44.72

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

6/20

Pullback

2/25

Volume

7/15

Valuation

11/20

TP/AR

1/10

Options

7/10

RSI

59.2

Range 1M

66.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

13/30

Estimates

6/20

Inst/Vol

0/15

Options

5/10

EPS Yr

-8.6%

EPS NY

0.3%

52W%

20.3%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +261.3% upside

Quality

30/30

Valuation

19/30

Growth

11/25

Stability

3/10

LT Trend

5/5

Upside

+261.3%

Quality

MoS

-14%

Novo Nordisk A/S

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 67900

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

NVO

Latest News

—

Caricamento notizie per NVO…

stock quote shares NVO – Novo Nordisk A/S Stock Price stock today

news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch NVO – Novo Nordisk A/S yahoo finance google finance

stock history NVO – Novo Nordisk A/S invest stock market

stock prices NVO premarket after hours

ticker NVO fair value insiders trading

OGN – Organon & Co.

OGN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.46

Margin Of Safety %

Put/Call OI Ratio

0.87

EPS Next Q Diff

0.22

EPS Last/This Y

2.72

EPS This/Next Y

0.22

Price

13.41

Target Price

11.25

Analyst Recom

3.5

Performance Q

81.39

Upside

-8.8%

Beta

1.54

Ticker: OGN

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-16	OGN	9.34	0.52	0.34	136374
2026-04-17	OGN	9.76	0.52	0.18	146704
2026-04-20	OGN	9.25	0.55	0.94	133162
2026-04-21	OGN	8.85	0.56	1.19	138870
2026-04-22	OGN	9.15	0.60	0.03	144712
2026-04-23	OGN	8.6	0.49	0.07	165995
2026-04-24	OGN	11.26	0.45	0.27	177355
2026-04-27	OGN	13.17	0.43	0.36	219000
2026-04-28	OGN	13.32	0.53	0.20	226093
2026-04-29	OGN	13.34	0.67	0.09	214216
2026-04-30	OGN	13.25	0.64	1.26	221138
2026-05-01	OGN	13.3	0.65	0.24	222071
2026-05-04	OGN	13.27	0.66	0.09	221700
2026-05-05	OGN	13.35	0.66	0.23	221460
2026-05-06	OGN	13.39	0.66	2.34	220880
2026-05-07	OGN	13.31	0.67	0.43	221873
2026-05-08	OGN	13.35	0.68	4.71	222802
2026-05-11	OGN	13.32	0.89	0.16	194765
2026-05-12	OGN	13.3	0.88	0.10	195877
2026-05-13	OGN	13.33	0.87	0.66	196741
2026-05-14	OGN	13.35	0.87	0.02	196725
2026-05-15	OGN	13.41	0.87	0.36	196647
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-16	OGN	9.34	-14.9	-	3.47
2026-04-17	OGN	9.76	-14.9	-	3.47
2026-04-20	OGN	9.25	-14.9	-	3.47
2026-04-21	OGN	8.85	-14.9	-	3.47
2026-04-22	OGN	9.14	-14.9	-	3.47
2026-04-23	OGN	8.60	-14.5	-	3.47
2026-04-24	OGN	11.28	-16.3	-	3.47
2026-04-27	OGN	13.16	-16.3	-	3.45
2026-04-28	OGN	13.33	-16.3	-	3.45
2026-04-30	OGN	13.25	-16.3	-	3.45
2026-05-01	OGN	13.30	-16.3	-	3.45
2026-05-04	OGN	13.27	-16.3	-	3.45
2026-05-05	OGN	13.34	-7.9	-	3.44
2026-05-06	OGN	13.40	-7.9	-	3.44
2026-05-07	OGN	13.31	-7.9	-	3.44
2026-05-08	OGN	13.35	-7.9	-	3.44
2026-05-11	OGN	13.32	-7.9	-	3.44
2026-05-12	OGN	13.30	-7.9	-	3.44
2026-05-13	OGN	13.35	-7.9	-	3.44
2026-05-14	OGN	13.35	-7.9	-	3.44
2026-05-15	OGN	13.41	-7.9	-	3.44
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-16	OGN	5.78	-1.41	8.54
2026-04-17	OGN	5.78	-1.41	8.54
2026-04-20	OGN	5.78	-1.31	8.54
2026-04-21	OGN	5.78	-1.31	8.54
2026-04-22	OGN	5.78	-1.31	8.54
2026-04-23	OGN	5.78	-1.31	8.55
2026-04-24	OGN	5.18	-1.31	8.55
2026-04-27	OGN	5.18	-0.77	7.19
2026-04-28	OGN	5.18	-0.77	7.19
2026-04-29	OGN	5.18	-0.77	7.19
2026-04-30	OGN	5.18	-0.77	7.19
2026-05-01	OGN	5.13	-0.77	0
2026-05-04	OGN	5.13	-1.24	7.12
2026-05-05	OGN	5.13	-1.24	7.12
2026-05-06	OGN	5.13	-1.24	7.12
2026-05-07	OGN	7.36	-1.24	7.12
2026-05-08	OGN	7.36	-1.24	7.12
2026-05-11	OGN	7.36	-0.39	7.12
2026-05-12	OGN	7.36	-0.39	7.46
2026-05-13	OGN	7.07	-0.39	7.46
2026-05-14	OGN	1.94	-0.39	7.46
2026-05-15	OGN	1.94	-0.39	7.46
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.71

Avg. EPS Est. Current Quarter

0.92

Avg. EPS Est. Next Quarter

0.93

Insider Transactions

1.94

Institutional Transactions

-0.39

Beta

1.54

Average Sales Estimate Current Quarter

1556

Average Sales Estimate Next Quarter

1568

Fair Value

13.8

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-82.7

Target Price

11.25

P/E

14.28

Forward P/E

3.66

PEG

2.22

P/S

0.57

P/B

3.9

P/Free Cash Flow

5.15

EPS

0.94

Average EPS Est. Cur. Y

3.44

EPS Next Y. (Est.)

3.66

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.99

Relative Volume

0.37

Return on Equity vs Sector %

0.3

Return on Equity vs Industry %

-9.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

◆ OGN Healthcare

$13.40

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

6/20

Pullback

8/25

Volume

11/15

Valuation

8/20

TP/AR

0/10

Options

5/10

RSI

77.8

Range 1M

98.9%

Sup Dist

0.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

5/30

Estimates

3/20

Inst/Vol

4/15

Options

5/10

EPS Yr

-6%

EPS NY

6.4%

52W%

99.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +125.2% upside

Quality

15/30

Valuation

20/30

Growth

5/25

Stability

4/10

LT Trend

3/5

Upside

+125.2%

Quality

MoS

Organon & Co.

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 10000

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote development of ovarian follicles; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding and hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; oncology products, including Ontruzant and Aybintio; Bildyos and Bilprevda, a recombinant anti-RANKL human monoclonal antibodies; and Poherdy, a neu receptor antagonist. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products to control and prevent asthma symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company serves drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey.

OGN

Latest News

—

Caricamento notizie per OGN…

stock quote shares OGN – Organon & Co. Stock Price stock today

news today OGN – Organon & Co. stock forecast ,stock prediction 2023 2024 2025

marketwatch OGN – Organon & Co. yahoo finance google finance

stock history OGN – Organon & Co. invest stock market

stock prices OGN premarket after hours

ticker OGN fair value insiders trading

HZNP – Horizon Therapeutics Public Limited Company

HZNP — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.11

Margin Of Safety %

-6

Put/Call OI Ratio

EPS Next Q Diff

0.02

EPS Last/This Y

EPS This/Next Y

0.18

Price

116.3

Target Price

116.5

Analyst Recom

Performance Q

13.24

Upside

N/A

Beta

1.01

Ticker: HZNP

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-16	HZNP	116.3	N/A	N/A	0
2026-04-17	HZNP	116.3	N/A	N/A	0
2026-04-20	HZNP	116.3	N/A	N/A	0
2026-04-21	HZNP	116.3	N/A	N/A	0
2026-04-22	HZNP	116.3	N/A	N/A	0
2026-04-23	HZNP	116.3	N/A	N/A	0
2026-04-24	HZNP	116.3	N/A	N/A	0
2026-04-27	HZNP	116.3	N/A	N/A	0
2026-04-28	HZNP	116.3	N/A	N/A	0
2026-04-29	HZNP	116.3	N/A	N/A	0
2026-04-30	HZNP	116.3	N/A	N/A	0
2026-05-01	HZNP	116.3	N/A	N/A	0
2026-05-04	HZNP	116.3	N/A	N/A	0
2026-05-05	HZNP	116.3	N/A	N/A	0
2026-05-06	HZNP	116.3	N/A	N/A	0
2026-05-07	HZNP	116.3	N/A	N/A	0
2026-05-08	HZNP	116.3	N/A	N/A	0
2026-05-11	HZNP	116.3	N/A	N/A	0
2026-05-12	HZNP	116.3	N/A	N/A	0
2026-05-13	HZNP	116.3	N/A	N/A	0
2026-05-14	HZNP	116.3	N/A	N/A	0
2026-05-15	HZNP	116.3	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

Last Quarter Act. EPS

1.2

Avg. EPS Est. Current Quarter

1.22

Avg. EPS Est. Next Quarter

1.4

Insider Transactions

Institutional Transactions

1.83

Beta

1.01

Average Sales Estimate Current Quarter

954

Average Sales Estimate Next Quarter

1040

Fair Value

109.22

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

3.5

Max Drawdown 5-Year %

-50.9

Target Price

116.5

P/E

62.16

Forward P/E

18.11

PEG

12.43

P/S

7.31

P/B

5.01

P/Free Cash Flow

27.79

EPS

1.87

Average EPS Est. Cur. Y

4.64

EPS Next Y. (Est.)

5.66

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

12.02

Relative Volume

Return on Equity vs Sector %

-13.1

Return on Equity vs Industry %

-15.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

1038.8

No data found for HZNP

HZNP

Latest News

—

Caricamento notizie per HZNP…

stock quote shares HZNP – Horizon Therapeutics Public Limited Company Stock Price stock today

news today HZNP – Horizon Therapeutics Public Limited Company stock forecast ,stock prediction 2023 2024 2025

marketwatch HZNP – Horizon Therapeutics Public Limited Company yahoo finance google finance

stock history HZNP – Horizon Therapeutics Public Limited Company invest stock market

stock prices HZNP premarket after hours

ticker HZNP fair value insiders trading

No more stocks to show

AMRN – Amarin Corp ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: AMRN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

GRFS – Grifols, S.A.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: GRFS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y